Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isavuconazole Prophylaxis in AML Chemotherapy
NCT00413439Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- May 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isavuconazole in invasive fungal infection (IFI), sponsored by Basilea Pharmaceutica. Started May 2006; status: completed.
02
Drugs
isavuconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00413439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413439.